BC Platforms Collaborated with Genomenon to Enhance Rare Disease Diagnostics and Research

ZURICH and BOSTON, Feb. 23: BC Platforms, a worldwide pioneer in healthcare data management, analytics and access revealed that it has entered a partnership with AI-driven genomics company, Genomenon (Ann Arbor, Michigan USA). The collaboration is concentrated on two fronts. Firstly, with the vision to advance clinical genomics, Genomenon's Mastermind Genomic Search Engine will be combined into BC Platforms' genomic analysis and interpretation platform BC|GENOME. On the research side, Mastermind will also be integrated into BC Platforms' research platform BC|INSIGHT to expedite complex genomic research by simplifying genomic data annotations and thus permitting AI/ML applications. Genomenon's Mastermind uses AI-driven genomics to accelerate variant interpretation, providing immediate insight into the full text of millions of scientific articles. Mastermind identifies every genomic association supported by the medical evidence, drawing informative connections between genes, variants, copy number variants (CNVs), diseases, phenotypes, therapies, and categorical keywords to inform both clinical care and drug discovery. By allowing users to find, connect, explore, and understand the links between genomic concepts of interest, Mastermind elevates the efficiency and accuracy of the clinical decision-making process. Personalized medicine platform powered by BC|GENOME is a highly interoperable and configurable genomics platform for clinical grade genomic data production, analysis and interpretation. Combining automation with a glass box approach, it is the solution of choice for leading healthcare organisations and genomics labs globally. Discovery and research platform powered by BC|INSIGHT is a highly scalable research data management solution for managing healthcare data, conducting studies as well as enabling research collaborations by proving a trusted research environment. Through its built-in patient data logic, ability to handle all data types and robust access management, the solution has been a preferred platform for over 20 years for a wide range of research environments from single cohort to population scale. Tero Silvola, CEO of BC Platforms, said, "We are delighted to be working with Genomenon, and enhancing the value of its outstanding 'Mastermind' Genomic Search Engine to healthcare and research collaborators. Mastermind is the only one of its kind, delivering insight into the full text of genomic literature in the blink of an eye. Genomenon is a natural partner for us as both companies are passionate about powering evidence-based genomics. This is about super-charging data-driven decision-making in healthcare." Mike Klein, CEO of Genomenon, said, "We look forward to this collaboration and share BC Platforms' commitment to deliver the most comprehensive source of genomic evidence to researchers and clinicians working on the frontiers of medical science."